Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-5777
Authors: Huppertz, Tilman
Horstmann, Vera
Scharnow, Charlotte
Ruckes, Christian
Bahr, Katharina
Matthias, Christoph
Gouveris, Haralampos
Title: OSA in patients with head and neck cancer is associated with cancer size and oncologic outcome
Online publication date: 9-Jun-2021
Language: english
Abstract: PURPOSE Obstructive sleep apnea (OSA) is associated with severe daytime sleepiness and reduced quality of life. These symptoms are also present in patients with squamous cell carcinoma of the head and neck (SCCHN) before, during and after treatment, so that comorbidity cannot be excluded. The aim was to evaluate the prevalence of OSA and its impact on the quality of life in patients with oropharyngeal, hypopharyngeal and lateral tongue SCCHN in a prospective study. METHODS We performed cardiorespiratory home sleep apnea testing and recorded sleep-related patient-reported outcomes in 33 patients with confirmed oropharyngeal, hypopharyngeal and lateral tongue SCCHN. We correlated the sleep-related variables to oncologic variables and endpoints. RESULTS Five female and 28 male patients with SCCHN (aged 46–77 years) were recruited. Thirty patients (90%) had OSA as defined by an Apnea/Hypopnea Index (AHI) > 5 /h before treatment. Evaluation after treatment, which was possible in 17 patients, showed OSA in 16 patients (94%). Radiologic primary tumor size showed significant positive correlation with AHI and apnea-index. Tumor recurrence and tumor-related mortality showed significant positive association with AHI. PSQI of these patients showed at least a moderate sleep disturbance. EORTC QLQ c30 questionnaire showed reduced values for all tested qualities, in particular for fatigue, insomnia, pain and financial distress. CONCLUSION Obstructive sleep apnea is a significant comorbidity in patients with SCCHN. Pre-interventional AHI may be correlated with the oncologic outcome. Further research is needed to further describe the course of OSA and its treatment before, during and after therapy.
DDC: 610 Medizin
610 Medical sciences
Institution: Johannes Gutenberg-Universität Mainz
Department: FB 04 Medizin
Place: Mainz
DOI: http://doi.org/10.25358/openscience-5777
Version: Published version
Publication type: Zeitschriftenaufsatz
License: CC-BY
Information on rights of use: https://creativecommons.org/licenses/by/4.0/
Journal: European archives of oto-rhino-laryngology and head & neck
278
Pages or article number: 2485
2491
Publisher: Springer
Publisher place: Berlin u.a.
Issue date: 2021
ISSN: 1434-4726
Publisher's URL: https://doi.org/10.1007/s00405-020-06355-3
Appears in collections:JGU-Publikationen

Files in This Item:
File Description SizeFormat 
huppertz_tilman-osa_in_patient-20210609111551653.pdf425.14 kBAdobe PDFView/Open